RT-PCR analysis revealed that among these candidates, MMP-1 exhibited the most significant differential expression (Supplementary Figure 2), identifying it as a target for further investigation to clarify the specific signaling pathway through which AGBL4 may promote GBM tumor progression. This evidence concerns the gene MMP1 and glioblastoma.